Viewing StudyNCT04318223



Ignite Creation Date: 2024-05-06 @ 2:25 PM
Last Modification Date: 2024-10-26 @ 1:31 PM
Study NCT ID: NCT04318223
Status: UNKNOWN
Last Update Posted: 2020-03-23
First Post: 2019-12-02

Brief Title: Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK46 Inhibitor in Combination With Hormonal Therapy
Sponsor: Consorzio Oncotech
Organization: Consorzio Oncotech

Organization Data

Organization: Consorzio Oncotech
Class: OTHER
Study ID: GIM24-PALBO-BP
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Consorzio Oncotech
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators